Distribution of CB1 cannabinoid receptors and their relationship with mu-opioid receptors in the rat periaqueductal gray
Open accessAbstract
The periaqueductal gray (PAG) is part of a descending pain modulatory system that, when activated, produces widespread and profound antinociception. Microinjection of either opioids or cannabinoids into the PAG elicits antinociception. Moreover, microinjection of the cannabinoid 1 (CB1) receptor agonist HU-210 into the PAG enhances the antinociceptive effect of subsequent morphine injections, indicating a direct relationship between these two systems. The objective of this study was to characterize the distribution of CB1 receptors in the dorsolateral and ventrolateral PAG in relationship to mu-opioid peptide (MOP) receptors. Immunocytochemical analysis revealed extensive and diffuse CB1 receptor labeling in the PAG, 60% of which was found in somatodendritic profiles. CB1 and MOP receptor immunolabeling were co-localized in 32% of fluorescent Nissl-stained cells that were analyzed. Eight percent (8%) of PAG neurons that were MOP receptor-immunoreactive (-ir) received CB1 receptor-ir appositions. Ultrastructural analysis confirmed the presence of CB1 receptor-ir somata, dendrites and axon terminals in the PAG. These results indicate that behavioral interactions between cannabinoids and opioids may be the result of cellular adaptations within PAG neurons co-expressing CB1 and MOP receptors.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
The rat brain in stereotaxic coordinates
Palkovits, M. (1983) · Neuropeptides · doi:10.1016/0143-4179(83)90049-5 · Cited by 28,959 · see citing works
The Rat Brain in Stereotaxic Coordinates
Paxinos, G., & Watson, C. (1983) · Elsevier eBooks · doi:10.1016/c2009-0-63235-9 · Cited by 28,585 · see citing works
Abràmoff, M. D., Magalhães, P. J., & Ram, S. J. (2004) · Utrecht University Repository (Utrecht University) · Cited by 11,816 · see citing works
International Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels
Catterall, W. A., Chandy, K. G., Clapham, D. E., Gutman, G. A., Hofmann, F., Harmar, A. J., Abernethy, D. R., & Spedding, M. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.4.5 · Cited by 7,126 · see citing works
International Union of Pharmacology. XXVII. Classification of Cannabinoid Receptors
Howlett, A. C., Barth, F., Bonner, T. I., Cabral, G., Casellas, P., Devane, W. A., Felder, C. C., Herkenham, M., Mackie, K., Martin, B. R., et al. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.2.161 · Cited by 2,819 · see citing works
Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses
Wilson, R. I., & Nicoll, R. A. (2001) · Nature · doi:10.1038/35069076 · Cited by 1,607 · see citing works
Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system
Tsou, K., Brown, S., Sañudo-Peña, M. C., Mackie, K., & Walker, J. M. (1998) · Neuroscience · doi:10.1016/s0306-4522(97)00436-3 · Cited by 1,586 · see citing works
(1991) · Medical Entomology and Zoology · Cited by 1,512 · see citing works
Endocannabinoid Signaling in the Brain
Wilson, R. I., & Nicoll, R. A. (2002) · Science · doi:10.1126/science.1063545 · Cited by 1,260 · see citing works
μ-Opioid receptor desensitization by β-arrestin-2 determines morphine tolerance but not dependence
Bohn, L., Gainetdinov, R. R., Lin, F., Lefkowitz, R. J., & Caron, M. G. (2000) · Nature · doi:10.1038/35047086 · Cited by 930 · see citing works
An endocannabinoid mechanism for stress-induced analgesia
Hohmann, A. G., Suplita, R. L., Bolton, N. M., Neely, M. H., Fegley, D., Mangieri, R., Krey, J. F., Michael Walker, J., Holmes, P. V., Crystal, J. D., et al. (2005) · Nature · doi:10.1038/nature03658 · Cited by 778 · see citing works
Mailleux, P., & Vanderhaeghen, J. (1992) · Neuroscience · doi:10.1016/0306-4522(92)90409-u · Cited by 663 · see citing works
Retrograde signaling in the regulation of synaptic transmission: focus on endocannabinoids
Alger, B. E. (2002) · Progress in Neurobiology · doi:10.1016/s0301-0082(02)00080-1 · Cited by 599 · see citing works
Cannabinoids inhibit hippocampal GABAergic transmission and network oscillations
Hájos, N., Katona, I., Naiem, S. S., Mackie, K., Ledent, C. A., Módy, I., & Freund, T. F. (2000) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2000.00217.x · Cited by 533 · see citing works
Cannabinoid Receptor Signaling
Howlett, A. C. (2005) · Springer eBooks · doi:10.1007/3-540-26573-2_2 · Cited by 451 · see citing works
Chan, J., Aoki, C. J., & Pickel, V. M. (1990) · Journal of Neuroscience Methods · doi:10.1016/0165-0270(90)90015-8 · Cited by 447 · see citing works
Cameron, A. A., Khan, I. A., Westlund, K. N., & Willis, W. D. (1995) · The Journal of Comparative Neurology · doi:10.1002/cne.903510408 · Cited by 353 · see citing works
Cannabinoid–Opioid Interaction in Chronic Pain
Abrams, D. I., Couey, P., Shade, S. B., Kelly, M. E., & Benowitz, N. L. (2011) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2011.188 · Cited by 319 · see citing works
Analysis of opioid efficacy, tolerance, addiction and dependence from cell culture to human
Morgan, M. M., & Christie, M. J. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01335.x · Cited by 273 · see citing works
Self-citationLichtman, A. H., Cook, S. A., & Martin, B. R. (1996) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12310-0 · Cited by 261 · see citing works
OPIOID RECEPTOR SIGNALLING MECHANISMS
Connor, M. A., & Christie, M. J. (1999) · Clinical and Experimental Pharmacology and Physiology · doi:10.1046/j.1440-1681.1999.03049.x · Cited by 259 · see citing works
Howlett, A. C. (1985) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)12377-8 · Cited by 257 · see citing works
Jensen, T. S., & Yaksh, T. L. (1986) · Brain Research · doi:10.1016/0006-8993(86)90662-1 · Cited by 214 · see citing works
An examination of the central sites of action of cannabinoid-induced antinociception in the rat
Martin, W. J., Patrick, S. L., Coffin, P. O., Tsou, K., & Walker, J. M. (1995) · Life Sciences · doi:10.1016/0024-3205(95)00195-c · Cited by 165 · see citing works
Enhanced Opioid Efficacy in Opioid Dependence Is Caused by an Altered Signal Transduction Pathway
Ingram, S., Vaughan, C. W., Bagley, E. E., Connor, M. A., & Christie, M. J. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-24-10269.1998 · Cited by 161 · see citing works
Mukhopadhyay, P., Pan, H., Rajesh, M., Bátkai, S., Patel, V., Harvey-White, J. D., Mukhopadhyay, B., Haskó, G., Gao, B., Mackie, K., et al. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00769.x · Cited by 156 · see citing works
Antinociceptive Synergy between Δ9-Tetrahydrocannabinol and Opioids after Oral Administration
Cichewicz, D. L., & McCarthy, E. A. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.045575 · Cited by 154 · see citing works
Bailey, T. W., Hermes, S. M., Andresen, M. C., & Aicher, S. A. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.2044-06.2006 · Cited by 147 · see citing works
Self-citationThe Enhancement of Morphine Antinociception in Mice by Î9-Tetrahydrocannabinol
Smith, F. (1998) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(98)00012-4 · Cited by 146 · see citing works
Dimerization of G protein-coupled receptors: CB1 cannabinoid receptors as an example
Wager‐Miller, J., Westenbroek, R. E., & Mackie, K. (2002) · Chemistry and Physics of Lipids · doi:10.1016/s0009-3084(02)00151-2 · Cited by 144 · see citing works
Finn, D. P., Jhaveri, M. D., Beckett, S. R. G., Roe, C. H., Kendall, D. A., Marsden, C. A., & Chapman, V. (2003) · Neuropharmacology · doi:10.1016/s0028-3908(03)00235-1 · Cited by 136 · see citing works
Kalyuzhny, A. E., Arvidsson, U., Wu, W., & Wessendorf, M. W. (1996) · Journal of Neuroscience · doi:10.1523/jneurosci.16-20-06490.1996 · Cited by 126 · see citing works
Suárez, J., Bermúdez‐Silva, F. J., Mackie, K., Ledent, C. A., Zimmer, A., Cravatt, B. F., & de Fonseca, F. R. (2008) · The Journal of Comparative Neurology · doi:10.1002/cne.21774 · Cited by 126 · see citing works
Pugh, G., Smith, P. B., Dombrowski, D. S., & Welch, S. P. (1996) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)21168-5 · Cited by 123 · cited 4× · see citing works
“In CB1 receptor-ir axon terminals, 87% of the gold particles were cytoplasmic, while the remaining 13% were plasmalemmal, which is consistent with CB1 receptor immunoreactivity in the dorsal horn of the spinal cord (Pugh et al., 1996).”
BackgroundResultInfluentialMorgan, M. M., Whitney, P. K., & Gold, M. S. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00669-6 · Cited by 119 · see citing works
Self-citationCichewicz, D. L., & Welch, S. P. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.046870 · Cited by 110 · see citing works
K�ppenbender, K. D., Standaert, D. G., Feuerstein, T. J., Penney, J. B., Young, A. B., & Landwehrmeyer, G. B. (2000) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(20000417)419:4 · Cited by 104 · see citing works
Self-citationSynergistic affective analgesic interaction between delta-9-tetrahydrocannabinol and morphine
Roberts, J. D., Gennings, C., & Shih, M. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.11.036 · Cited by 103 · see citing works
Tham, S. M., Angus, J. A., Tudor, E. M., & Wright, C. E. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706045 · Cited by 98 · see citing works
Opioid and Cannabinoid Receptor Inhibition of Adenylyl Cyclase in Braina
Childers, S. R., FLEMING, L., KONKOY, C., MARCKEL, D., Pacheco, M. A., Sexton, T., & Ward, S. J. (1992) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1992.tb25954.x · Cited by 95 · see citing works
Scavone, J. L., Mackie, K., & Bockstaele, E. J. V. (2009) · Brain Research · doi:10.1016/j.brainres.2009.11.023 · Cited by 92 · see citing works
Interaction of the cannabinoid and opioid systems in the modulation of nociception
Welch, S. P. (2009) · International Review of Psychiatry · doi:10.1080/09540260902782794 · Cited by 92 · see citing works
Fattore, L., Viganò, D., Fadda, P., Rubino, T., Fratta, W., & Parolaro, D. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05470.x · Cited by 89 · see citing works
Smith, P. A., Selley, D. E., Sim-Selley, L. J., & Welch, S. P. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.06.001 · Cited by 81 · cited 6× · see citing works
“…antinociception (Cichewicz and McCarthy, 2003; Tham et al., 2005; Roberts et al., 2006; Smith et al., 2007), and systemic pre-treatment or co-administration of cannabinoids attenuates the development of morphine tolerance (Cichewicz and Welch, 2003; Smith et al., 2007; Wilson et al., 2008).”
BackgroundInfluentialAicher, S. A., Punnoose, A., & Goldberg, A. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-11-04345.2000 · Cited by 81 · see citing works
Self-citationModulation of rat brain cannabinoid receptors after chronic morphine treatment
Rubino, T., Tizzoni, L., Viganò, D., Massi, P., & Parolaro, D. (1997) · Neuroreport · doi:10.1097/00001756-199710200-00007 · Cited by 77 · see citing works
Finn, D. P., Beckett, S. R. G., Roe, C. H., Madjd, A., Fone, K. C. F., Kendall, D. A., Marsden, C. A., & Chapman, V. (2004) · European Journal of Neuroscience · doi:10.1111/j.0953-816x.2004.03177.x · Cited by 76 · see citing works
Aicher, S. A., Sharma, S. K., Cheng, P. Y., & Pickel, V. M. (1997) · Brain Research · doi:10.1016/s0006-8993(97)00637-9 · Cited by 74 · see citing works
Self-citationMeng, I. D., & Johansen, J. P. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2003.10.001 · Cited by 65 · see citing works
Endocannabinoid system in the adult rat circumventricular areas: An immunohistochemical study
Suárez, J., Romero‐Zerbo, S., Rivera, P., Bermúdez‐Silva, F. J., Pérez, J., de Fonseca, F. R., & Fernández‐Llebrez, P. (2010) · The Journal of Comparative Neurology · doi:10.1002/cne.22382 · Cited by 56 · see citing works
Wilson, A. R., Maher, L., & Morgan, M. M. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.07.038 · Cited by 52 · see citing works
Self-citationMacey, T. A., Bobeck, E. N., Hegarty, D. M., Aicher, S. A., Ingram, S., & Morgan, M. M. (2009) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.152157 · Cited by 47 · see citing works
Self-citationHegarty, D. M., Tonsfeldt, K. J., Hermes, S. M., Helfand, H., & Aicher, S. A. (2010) · The Journal of Comparative Neurology · doi:10.1002/cne.22414 · Cited by 47 · see citing works
Self-citationAsensio, V. J., Miralles, A., & Garcı́a-Sevilla, J. A. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.04.001 · Cited by 41 · see citing works
Laurentiis, A. D., Fernández‐Solari, J., Mohn, C. E., Burdet, B., Zubilete, M. A. Z., & Rettori, V. (2010) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2010.02.006 · Cited by 36 · see citing works
Cichewicz, D. L., Welch, S. P., & Smith, F. L. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.09.039 · Cited by 33 · see citing works
Aicher, S. A., Mitchell, J., Swanson, K. R., & Zadina, J. E. (2003) · Brain Research · doi:10.1016/s0006-8993(03)02678-7 · Cited by 26 · see citing works
Self-citationDrake, C. T., Aicher, S. A., Montalmant, F., & Milner, T. A. (2005) · Experimental Neurology · doi:10.1016/j.expneurol.2005.08.012 · Cited by 19 · see citing works
Self-citationHegarty, D. M., Mitchell, J., Swanson, K. R., & Aicher, S. A. (2007) · Brain Research · doi:10.1016/j.brainres.2007.09.070 · Cited by 13 · see citing works
Self-citationInteraction between ? 9-tetrahydrocannabinol and morphine on the motor activity of mice
Ayhan, I. H., Kaymak�alan, S., & Tulunay, F. C. (1979) · Psychopharmacology · doi:10.1007/bf00429697 · Cited by 11 · see citing works
Hagihara (1999) · doi:10.1002/(sici)1096-9861(19990726)410:2
Flagged first, then by citations
1 of the 62 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Donvito, G., Nass, S. R., Wilkerson, J. L., Curry, Z. A., Schurman, L. D., Kinsey, S. G., & Lichtman, A. H. (2018) · Neuropsychopharmacology · doi:10.1038/npp.2017.204 · Cited by 301 · see citing works
Emerging Evidence for Cannabis' Role in Opioid Use Disorder
Wiese, B. M., & Wilson‐Poe, A. R. (2018) · Cannabis and Cannabinoid Research · doi:10.1089/can.2018.0022 · Cited by 156 · see citing works
Self-citationChronic pain patients' perspectives of medical cannabis
Piper, B. J., Beals, M. L., Abess, A. T., Nichols, S. D., Martin, M. W., Cobb, C. M., & DeKeuster, R. M. (2017) · Pain · doi:10.1097/j.pain.0000000000000899 · Cited by 124 · see citing works
Sierra, S., Luquin, N., Rico, A. J., Gómez-Bautista, V., Roda, E., Dopeso‐Reyes, I. G., Vázquez, A., Martínez‐Pinilla, E., Labandeira-García, J. L., Franco, R., et al. (2014) · Brain Structure and Function · doi:10.1007/s00429-014-0823-8 · Cited by 103 · see citing works
Endogenous opiates and behavior: 2012
Bodnar, R. J. (2013) · Peptides · doi:10.1016/j.peptides.2013.10.001 · Cited by 98 · see citing works
Molecular Mechanism and Cannabinoid Pharmacology
Schurman, L. D., Lu, D., Kendall, D. A., Howlett, A. C., & Lichtman, A. H. (2019) · Handbook of experimental pharmacology · doi:10.1007/164_2019_298 · Cited by 102 · see citing works
Medical cannabis ‒ the Canadian perspective
Ramkellawan, S., Bober, S., Mindra, S., Moreau, J. M., & Ko, G. D. (2016) · Journal of Pain Research · doi:10.2147/jpr.s98182 · Cited by 91 · see citing works
Bushlin, I., Gupta, A., Stockton, S. D., Miller, L. K., & Devi, L. A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049789 · Cited by 90 · see citing works
Cannabinoid-hypocretin cross-talk in the central nervous system: what we know so far
Flores, Á., Maldonado, R. J., & Berrendero, F. (2013) · Frontiers in Neuroscience · doi:10.3389/fnins.2013.00256 · Cited by 68 · see citing works
Eidson, L. N., & Murphy, A. Z. (2013) · Journal of Pain · doi:10.1016/j.jpain.2012.12.010 · Cited by 65 · see citing works
Crawford, L. S., Mills, E. P., Hanson, T., Macey, P. M., Glarin, R., Macefield, V. G., Keay, K. A., & Henderson, L. A. (2021) · Journal of Neuroscience · doi:10.1523/jneurosci.0806-21.2021 · Cited by 90 · see citing works
Siqueira-Lima, P. S., Araújo, A. A. D. S., Angélica, M., Quintans, J. D. S. S., Menezes, P. D. P., Alves, P. B., Júnior, W. D. L., Santos, M. R. V., Bonjardim, L. R., & Quintans‐Júnior, L. J. (2013) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.12145 · Cited by 61 · see citing works
High Times for Painful Blues: The Endocannabinoid System in Pain-Depression Comorbidity
Fitzgibbon, M., Finn, D. P., & Roche, M. (2015) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyv095 · Cited by 57 · see citing works
Wilson‐Poe, A. R., Pocius, E., Herschbach, M., & Morgan, M. M. (2012) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2012.10.002 · Cited by 53 · see citing works
Self-citationGrim, T. W., Ghosh, S., Hsu, K.-L., Cravatt, B. F., Kinsey, S. G., & Lichtman, A. H. (2014) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2014.07.008 · Cited by 50 · see citing works
Involvement of cannabinoid receptors in peripheral and spinal morphine analgesia
Desroches, J., Bouchard, J., Gendron, L., & Beaulieu, P. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.12.030 · Cited by 49 · see citing works
Ly, H. G., Ceccarini, J., Weltens, N., Bormans, G., van Laere, K., Tack, J., & van Oudenhove, L. (2015) · Psychotherapy and Psychosomatics · doi:10.1159/000375454 · Cited by 44 · see citing works
Cannabinoids in the descending pain modulatory circuit: Role in inflammation
Bouchet, C. A., & Ingram, S. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107495 · Cited by 51 · see citing works
Differential effects of endocannabinoid catabolic inhibitors on morphine withdrawal in mice
Gamage, T. F., Ignatowska-Jankowska, B. M., Muldoon, P. P., Cravatt, B. F., Damaj, M. I., & Lichtman, A. H. (2015) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2014.11.015 · Cited by 40 · see citing works
Adult cyclical vomiting syndrome: a disorder of allostatic regulation?
Levinthal, D. J., & Bielefeldt, K. (2014) · Experimental Brain Research · doi:10.1007/s00221-014-3939-4 · Cited by 35 · see citing works
Mohammadkhani, A., & Borgland, S. L. (2020) · Journal of Neuroscience Research · doi:10.1002/jnr.24770 · Cited by 29 · see citing works
When orexins meet cannabinoids: Bidirectional functional interactions
Berrendero, F., Flores, Á., & Robledo, P. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.08.040 · Cited by 28 · see citing works
Hahn, A. H., Merullo, D. P., Spool, J. A., Angyal, C. S., Stevenson, S. A., & Riters, L. V. (2017) · Neuroscience · doi:10.1016/j.neuroscience.2017.01.028 · Cited by 28 · see citing works
Cannabinoid Ligands and Alcohol Addiction: A Promising Therapeutic Tool or a Humbug?
Kleczkowska, P., Smaga, I., Filip, M., & Bujalska‐Zadrożny, M. (2015) · Neurotoxicity Research · doi:10.1007/s12640-015-9555-7 · Cited by 27 · see citing works
Wills, K. L., & Parker, L. A. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00187 · Cited by 26 · see citing works
Shou, Y., Yang, Y., Xu, M., Zhao, Y., Ge, L.-B., & Zhang, B. (2013) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2013/393460 · Cited by 22 · see citing works
Molecular Mechanisms of Cannabis Signaling in the Brain
Ronan, P. J., Wongngamnit, N., & Beresford, T. P. (2015) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2015.10.002 · Cited by 23 · see citing works
Effects of inflammatory pain on CB1 receptor in the midbrain periaqueductal gray
Wilson‐Poe, A. R., Wiese, B. M., Kibaly, C., Lueptow, L. M., Garcia, J. J., Anand, P., Cahill, C. M., & Morón, J. A. (2021) · PAIN Reports · doi:10.1097/pr9.0000000000000897 · Cited by 20 · see citing works
Self-citationGPR171 Agonist Reduces Chronic Neuropathic and Inflammatory Pain in Male, But Not Female Mice
Ram, A., Edwards, T. M., McCarty, A., Afrose, L., McDermott, M., & Bobeck, E. N. (2021) · Frontiers in Pain Research · doi:10.3389/fpain.2021.695396 · Cited by 20 · see citing works
Iman, I. N., Ahmad, N. A. Z., Yusof, N. A. M., Talib, U. N., Norazit, A., Kumar, J., Mehat, M. Z., Hassan, Z., Müller, C. P., & Mustapha, M. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.708055 · Cited by 20 · see citing works
Interaction of Cannabis Use and Aging: From Molecule to Mind
Yoo, H. B., DiMuzio, J. M., & Filbey, F. M. (2019) · Journal of Dual Diagnosis · doi:10.1080/15504263.2019.1665218 · Cited by 19 · see citing works
Wilson‐Poe, A. R., Lau, B. K., & Vaughan, C. W. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12809 · Cited by 18 · see citing works
Self-citationDatta, U., Kelley, L. K., Middleton, J. W., & Gilpin, N. W. (2020) · Psychopharmacology · doi:10.1007/s00213-020-05650-5 · Cited by 18 · see citing works
Altun, A., Özdemir, E., Yıldırım, K., Gürsoy, S., Durmuş, N., & Bağcıvan, İ. (2015) · PubMed · doi:10.4149/gpb_2015017 · Cited by 16 · see citing works
McDermott, M., Afrose, L., Gomes, I., Devi, L. A., & Bobeck, E. N. (2019) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.119.259242 · Cited by 15 · see citing works
Bouchet, C. A., McPherson, K. B., Coutens, B., Janowsky, A. J., & Ingram, S. (2023) · Journal of Neuroscience · doi:10.1523/jneurosci.0037-23.2023 · Cited by 15 · see citing works
Lee, M. T., Mackie, K., & Chiou, L. (2021) · British Journal of Pharmacology · doi:10.1111/bph.15771 · Cited by 14 · see citing works
Lee, M. T., Chen, Y., Mackie, K., & Chiou, L. (2020) · Journal of Pain · doi:10.1016/j.jpain.2020.09.003 · Cited by 13 · see citing works
Wiese, B. M., Liktor‐Busa, E., Couture, S. A., Nikas, S. P., Ji, L., Liu, Y., Makriyannis, A., Spigelman, I., Vanderah, T. W., & Largent‐Milnes, T. M. (2021) · Cannabis and Cannabinoid Research · doi:10.1089/can.2021.0090 · Cited by 11 · see citing works
Postoperative Opioid Use Among Opioid-Naive Cannabis Users Following Single-Level Lumbar Fusions
Khalid, S. I., Jiang, S. H., Khilwani, H., Thomson, K. B., Mirpuri, P., & Mehta, A. I. (2023) · World Neurosurgery · doi:10.1016/j.wneu.2023.04.001 · Cited by 12 · see citing works
Ibrahim, B. M., & Abdel‐Rahman, A. A. (2015) · Brain Research · doi:10.1016/j.brainres.2015.06.011 · Cited by 11 · see citing works
Unveiling the link between chronic pain and misuse of opioids and cannabis
Dagher, M., Alayoubi, M., Sigal, G. H., & Cahill, C. M. (2024) · Journal of Neural Transmission · doi:10.1007/s00702-024-02765-3 · Cited by 11 · see citing works
Review of systemic and syndromic complications of cannabis use: A review
Shah, J., & Fermo, O. P. (2022) · Medicine · doi:10.1097/md.0000000000032111 · Cited by 10 · see citing works
Salviati, E., Guida, F., Gioia, D. L., Merciai, F., Maione, S., Marzo, V. D., Campiglia, P., Piscitelli, F., & Sommella, E. (2025) · Talanta · doi:10.1016/j.talanta.2025.127811 · Cited by 9 · see citing works
Tamaddonfard, E., Erfanparast, A., Salighedar, R., & Tamaddonfard, S. (2019) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-019-01735-x · Cited by 9 · see citing works
Dean, C., Hillard, C. J., Seagard, J. L., Hopp, F. A., & Hogan, Q. H. (2017) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00481.2016 · Cited by 9 · see citing works
Amissah, R. Q., Kayır, H., Talhat, M. A., Hassan, A., Gu, Y., Johnson, R., Urban, K., & Khokhar, J. Y. (2024) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.123.001987 · Cited by 8 · see citing works
Leśniak, A., Chmielewska, D., Poznański, P., Bujalska‐Zadrożny, M., Strzemecka, J., & Sacharczuk, M. (2019) · Neuroscience · doi:10.1016/j.neuroscience.2019.02.015 · Cited by 8 · see citing works
Vivanco-Estela, A. N., da Rocha, S. A., Escobar-Espinal, D. M., Bálico, G. G., Caudle, R. M., Guimarães, F. S., Del-Bel, E., & Nascimento, G. C. (2025) · Pain · doi:10.1097/j.pain.0000000000003616 · Cited by 7 · see citing works
Pearl‐Dowler, L., Posa, L., López-Canul, M., Teggin, A., & Gobbi, G. (2023) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2023.110805 · Cited by 7 · see citing works
Tryon, V. L., Mizumori, S. J. Y., & Morgan, M. M. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2016.08.025 · Cited by 7 · see citing works
Self-citationAntiallodynic effect of PhAR‐DBH‐Me involves cannabinoid and TRPV1 receptors
Quiñonez‐Bastidas, G. N., Palomino‐Hernández, O., López‐Ortíz, M., Rocha-González, H. I., González‐Anduaga, G. M., Regla, I., & Navarrete, A. (2020) · Pharmacology Research & Perspectives · doi:10.1002/prp2.663 · Cited by 7 · see citing works
Hebert-Chatelain, E., Marsicano, G., & Desprez, T. (2021) · Mitochondrial Physiology and Vegetal Molecules · doi:10.1007/978-3-319-57371-7_8 · Cited by 4 · see citing works
Alton, H., Linz, E., Bi, G., Soler‐Cedeño, O., Maras, M., & Xi, Z. (2025) · Neuropsychopharmacology · doi:10.1038/s41386-025-02245-6 · Cited by 5 · see citing works
Emerging Psychotropic Drug for the Treatment of Trigeminal Pain: Salvinorin A
Quiñonez‐Bastidas, G. N., Grijalva-Contreras, L. E., Patiño‐Camacho, S. I., & Navarrete, A. (2024) · Pharmaceuticals · doi:10.3390/ph17121619 · Cited by 6 · see citing works
Godoi, M. M., Zangrossi, H., da Cunha, J. M., & Zanoveli, J. M. (2020) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2020.172938 · Cited by 5 · see citing works
Takemura, Y., Sudo, Y., Saeki, T., Kurata, S., Suzuki, T., Mori, T., & Uezono, Y. (2022) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2022.04.002 · Cited by 5 · see citing works
Lei, X., Yan, Y., Zeng, J., Wang, R., Li, S., Xiao, Z., & Liu, X. (2022) · Neurochemistry International · doi:10.1016/j.neuint.2022.105437 · Cited by 5 · see citing works
Shahsavari, F., Abbasnejad, M., Raoof, M., & Esmaeili‐Mahani, S. (2020) · Archives of Oral Biology · doi:10.1016/j.archoralbio.2020.104778 · Cited by 4 · see citing works
Cyclic vomiting syndrome: From pathophysiology to treatment
Jiménez‐Castillo, R. A., Frazier, R., Venkatesan, T., & Remes-Troche, J. M. (2024) · Revista de Gastroenterología de México (English Edition) · doi:10.1016/j.rgmxen.2024.06.001 · Cited by 4 · see citing works
GPR171 Agonist Reduces Chronic Neuropathic and Inflammatory Pain in Male, but not in Female MicePreprint
Ram, A., Edwards, T., McCarty, A., Afrose, L., McDermott, M. V., & Bobeck, E. N. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.04.16.440030 · Cited by 4 · see citing works
Lawley, S., Green, A., Johnson, C., & Burton, M. D. (2025) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-25-00806 · Cited by 3 · see citing works
Slivicki, R. A., Wang, J. G., Kucz, K. V., Folarin‐Hines, J., Nhat, V. T. T., Kravitz, A. V., Creed, M. C., & Gereau, R. W. (2026) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/j.jpet.2026.105008 · Cited by 3 · see citing works
Thrul, J., Rabinowitz, J. A., Reboussin, B. A., Maher, B. S., Anthony, J. C., & Ialongo, N. S. (2023) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2023.01.033 · Cited by 2 · see citing works
Amissah, R. Q., Kayır, H., Talhat, M. A., Hassan, A., Gu, Y., Johnson, R., Urban, K., & Khokhar, J. Y. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.03.15.532815 · Cited by 2 · see citing works
Chronic inflammatory pain and chronic THC vapor inhalation alter midbrain neuronal activity
Kelley, L. K., Gilpin, N. W., & Middleton, J. W. (2025) · Journal of Neurophysiology · doi:10.1152/jn.00456.2024 · Cited by 1 · see citing works
Scicluna, R. L., Kang, J. W. M., Everett, N. A., Badolato, C. J., Etchart, M. G., Kevin, R. C., Wilson, B. B., Boorman, D. C., Gordon, R., Anderson, L. L., et al. (2026) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2026.119277 · Cited by 1 · see citing works
Involvement of Serotonergic System in Cannabinoid Analgesia
Dogrul, A. B., Seyrek, M., Yalçın, B., & Ulugöl, A. (2013) · Springer eBooks · doi:10.1007/978-1-4614-7940-6_13 · Cited by 1 · see citing works
Nocheva, H., Tashev, R. E., Bocheva, A. I., Atanasova, D., Dandov, A. D., & Lazarov, N. (2020) · Biomedical Reviews · doi:10.14748/bmr.v31.7708 · Cited by 1 · see citing works
The Periaqueductal Grey in Opioid Tolerance and Chronic Pain
Ram, A. (2021) · Digital Commons - USU (Utah State University) · doi:10.26076/176b-0d1f · Cited by 1 · see citing works
Woyach, V. L., Sherman, K., Hillard, C. J., Hopp, F. A., Hogan, Q. H., & Dean, C. (2022) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00073.2022 · Cited by 1 · see citing works
Interplay between endocannabinoid and endovanilloid mechanisms in fear conditioning
Briânis, R. C., Andreotti, J. P., Moreira, F. A., & Iglesias, L. P. (2023) · Acta Neuropsychiatrica · doi:10.1017/neu.2023.54 · Cited by 1 · see citing works
Omar, M., Ouzzaouit, S., Moussafir, M., Skalli, S., Taghzouti, K., & Abboussi, O. (2024) · IBRO Neuroscience Reports · doi:10.1016/j.ibneur.2024.10.006 · Cited by 1 · see citing works
Bouchet, C. A., Janowsky, A. J., & Ingram, S. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.06.20.496891 · Cited by 1 · see citing works
Kelley, L. K., Lightfoot, S. H. M., Hill, M. N., Gilpin, N. W., & Middleton, J. W. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.09.23.461562
Síndrome de vómitos cíclicos: de la fisiopatología al tratamiento
Jiménez‐Castillo, R. A., Frazier, R., Venkatesan, T., & Remes-Troche, J. M. (2024) · Revista de Gastroenterología de México · doi:10.1016/j.rgmx.2024.06.001
Cannabis Instead of Opiates in a Survey of a PA Medical Marijuana Program
Nichols, T. W. (2024) · American Journal of Biomedical Science & Research · doi:10.34297/ajbsr.2024.21.002850
Ghafouri, B., Stensson, N., Simon, R. A., Mayo, L. M., Lund, E., Forsgren, M. F., Leinhard, O. D., Lundberg, P., & van Ettinger-Veenstra, H. (2025) · Scandinavian Journal of Pain · doi:10.1515/sjpain-2025-0023
Henderson, L. A., Crawford, L. S., & Keay, K. A. (2026) · Handbook of clinical neurology · doi:10.1016/b978-0-443-15736-3.00003-2
- Authors
- Wilson-Poe, A. R., Morgan, M. M., Aicher, S. A., & Hegarty, D. M.
- Affiliations
- Washington State University Vancouver (US)
- Oregon Health & Science University (US)
- Corresponding author
- Morgan, M.M.
- Aicher, S.A.
- Hegarty, D.M.
- Venue
- Neuroscience
- Publisher
- Elsevier BV
- Published
- 2012-06
- Volume
- 213
- Pages
- 191-200
- ISSN
- 0306-4522 (ISSN-L)
- PMC
- PMC3367071
- OpenAlex
- W2085789686
- Cited by
- 79
- References
- 62
- Citations by year
- 2026: 3 · 2025: 6 · 2024: 7 · 2023: 6 · 2022: 5 · 2021: 9 · 2020: 8 · 2019: 5 · 2018: 2 · 2017: 5 · 2016: 3 · 2015: 6 · 2014: 5 · 2013: 7 · 2012: 2
- FWCI
- 4.70
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute on Drug Abuse (DA-011322, R01DA011322, R03DA026591, DA026591)
- National Institute of Neurological Disorders and Stroke (P30NS061800)
- National Institute of Dental and Craniofacial Research (DE012640, R01DE012640)
- National Center for Research Resources (S10RR016858, RR-016858)
- Topics
- Health Sciences › Medicine › Pharmacology › Cannabis and Cannabinoid Research
- Health Sciences › Medicine › Physiology › Pain Mechanisms and Treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Keywords
- CB1 receptor, mu-opioid receptor, periaqueductal gray, receptor colocalization, descending pain modulation, antinociception, morphine, HU-210, opioid-cannabinoid interaction, receptor ultrastructure
- MeSH terms
- Animals, Immunohistochemistry, Male, Neurons, Periaqueductal Gray, Rats, Sprague-Dawley, Receptors, Opioid, mu, Microscopy, Confocal, Receptor, Cannabinoid, CB1, Microscopy, Electron, Transmission, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review